Andre Frenzel

Title: The Innovations of Andre Frenzel

Introduction

Andre Frenzel is a notable inventor based in Braunschweig, Germany. She has made significant contributions to the field of biotechnology, particularly in the development of targeted therapies. Her work focuses on creating innovative solutions that can improve patient outcomes in cancer treatment.

Latest Patents

One of her key patents is titled "HER-2 targeted bispecific compositions and methods for making and using the same." This patent discloses polypeptides and methods for creating bispecific antibody constructs. These constructs are covalently linked to an extended recombinant polypeptide that includes a barcode fragment, which can be released upon digestion by a protease. Additionally, the patent describes a Release Segment that can be proteolytically cleaved, allowing the bispecific antibody construct to be released from the extended recombinant polypeptide.

Career Highlights

Andre Frenzel is currently employed at Amunix Pharmaceuticals, Inc., where she continues to advance her research and development efforts. Her innovative work has led to the creation of therapies that target specific cancer cells, enhancing the effectiveness of treatment while minimizing side effects.

Collaborations

She collaborates with esteemed colleagues such as Volker Schellenberger and Eric Johansen, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Andre Frenzel's contributions to biotechnology and her innovative patent work exemplify the impact of targeted therapies in modern medicine. Her dedication to advancing cancer treatment through her inventions is commendable and highlights the importance of research in improving healthcare outcomes.